Extended-Release Intramuscular Naltrexone (VIVITROL®): A Review of Its Use in the Prevention of Relapse to Opioid Dependence in Detoxified Patients

Hepatic Safety of Injectable Extended-Release Naltrexone in Patients With Chronic Hepatitis C and HIV Infection

(2015) Mack C. Mitchell et al.   Journal of Studies on Alcohol and Drugs

Current and Potential Pharmacological Treatment Options for Maintenance Therapy in Opioid-Dependent Individuals

(2012) Jeanette M. Tetrault et al.   DRUGS

Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: Dose–effects and time-course

(2011) George E. Bigelow et al.   DRUG AND ALCOHOL DEPENDENCE

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

(2011) Evgeny Krupitsky et al.   LANCET

Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States

(2011) Howard G. Birnbaum et al.   PAIN MEDICINE

Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility

(2010) Marc J. Fishman et al.   ADDICTION

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage

(2010) Bradley M Mathers et al.   LANCET